Homburg, S.; Christensen, C.B.; Pedersen, M.; Sørensen, S.G.; Donia, M.; Svane, I.M.; Hendel, H.W.; Ellebaek, E.
Prospective Assessment of Fluorine-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) for Early Identification of Checkpoint-Inhibitor-Induced Pseudoprogression. Cancers 2024, 16, 964.
https://doi.org/10.3390/cancers16050964
AMA Style
Homburg S, Christensen CB, Pedersen M, Sørensen SG, Donia M, Svane IM, Hendel HW, Ellebaek E.
Prospective Assessment of Fluorine-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) for Early Identification of Checkpoint-Inhibitor-Induced Pseudoprogression. Cancers. 2024; 16(5):964.
https://doi.org/10.3390/cancers16050964
Chicago/Turabian Style
Homburg, Sif, Charlotte Birk Christensen, Magnus Pedersen, Simon Grund Sørensen, Marco Donia, Inge Marie Svane, Helle Westergren Hendel, and Eva Ellebaek.
2024. "Prospective Assessment of Fluorine-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) for Early Identification of Checkpoint-Inhibitor-Induced Pseudoprogression" Cancers 16, no. 5: 964.
https://doi.org/10.3390/cancers16050964
APA Style
Homburg, S., Christensen, C. B., Pedersen, M., Sørensen, S. G., Donia, M., Svane, I. M., Hendel, H. W., & Ellebaek, E.
(2024). Prospective Assessment of Fluorine-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) for Early Identification of Checkpoint-Inhibitor-Induced Pseudoprogression. Cancers, 16(5), 964.
https://doi.org/10.3390/cancers16050964
